Trial NCT04604132

View at ClinicalTrials.gov 
Org. Study IDs: DZB-CS-202

Last trial update was posted on 2024-04-04

MeSH Interventions

Albumin-Bound Paclitaxel Antibodies, Monoclonal Paclitaxel Ramucirumab

MeSH Conditions

Adenocarcinoma

Other Conditions

Gastric Adenocarcinoma

Stopping Reasons

Terminated prematurely for administrative reasons not related to patient safety.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID